Cargando…
Early detection rate changes from a brain‐responsive neurostimulation system predict efficacy of newly added antiseizure drugs
OBJECTIVE: Brain‐responsive neurostimulation (RNS System, NeuroPace) is used to treat medically refractory focal epilepsy and also provides long‐term ambulatory neurophysiologic data. We sought to determine whether these data could predict the clinical response to antiseizure drugs (ASDs). METHODS:...
Autores principales: | Quraishi, Imran H., Mercier, Michael R., Skarpaas, Tara L., Hirsch, Lawrence J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003822/ https://www.ncbi.nlm.nih.gov/pubmed/31849045 http://dx.doi.org/10.1111/epi.16412 |
Ejemplares similares
-
Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine‐resistant amygdala kindling model
por: Metcalf, Cameron S., et al.
Publicado: (2019) -
Evaluation of subchronic administration of antiseizure drugs in spontaneously seizing rats
por: Thomson, Kyle E., et al.
Publicado: (2020) -
Sleep disruption is not observed with brain‐responsive neurostimulation for epilepsy
por: Ruoff, Leslie, et al.
Publicado: (2020) -
Real‐world experience with direct brain‐responsive neurostimulation for focal onset seizures
por: Razavi, Babak, et al.
Publicado: (2020) -
Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman‐induced epileptogenesis and brain pathology in rats
por: Lumley, Lucille A., et al.
Publicado: (2021)